OPKO Health, Inc.

Quick facts

Marketed products

• Calcifediol Oral Capsule
• Calcifediol Oral Product · Endocrinology / Nephrology
  Calcifediol is an active vitamin D metabolite that binds to the vitamin D receptor to regulate calcium and phosphate homeostasis and modulate immune function.
• Rayaldee · Other

Phase 3 pipeline

• CTAP101 Capsules · Nephrology / Endocrinology
  CTAP101 is a capsule formulation of calcitriol (active vitamin D) that enhances calcium absorption and regulates calcium-phosphate metabolism.

Phase 2 pipeline

• Cohort 1 CTAP101 Capsules- 60µg
• Cohort 1 CTAP101 Capsules - 90µg · Osteoporosis
  CTAP101 is a recombinant human parathyroid hormone-related protein (PTHrP) analogue.
• Cohort 1 Matching Sugar Capsule
• Cohort 2 CTAP101 Capsules - 30µg · Bone disorders
  CTAP101 is a recombinant human parathyroid hormone-related protein (PTHrP) analogue.
• CTA018 cream · Dermatology
  CTA018 cream is a topical corticosteroid used to treat inflammatory skin conditions.
• OPK-88003

Phase 1 pipeline

• E1 and G1
• EMZ702
• MOD-5014
• MOD-6031
• TT301

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• OPKO Health, Inc. portfolio CI brief
• OPKO Health, Inc. pipeline updates RSS